AAOpt 2024: Eye care provider and patient satisfaction with lifitegrast

News
Video

Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.

Melissa Barnett, OD, FAAO, FSLS, discussed a real-world study on eye care professional and patient satisfaction with the dry eye treatment lifitegrast (Xiidra) at this year's American Academy of Optometry meeting. The study had a retrospective cross-sectional design and surveyed 12 eye care practitioners, including 6 ophthalmologists and 6 optometrists, about their experiences prescribing lifitegrast to an average of 1288 patients with dry eye disease. The key findings were:

  • On average, 21% of dry eye patients seen by ophthalmologists and 17% of those seen by optometrists were treated with lifitegrast.
  • Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, such as increased tear film breakup time, reduced corneal and conjunctival staining, and increased tear meniscus height.
  • Practitioners also reported moderate to high satisfaction with lifitegrast's ability to improve dry eye symptoms like itching, dryness, burning/stinging, redness, pain, light sensitivity, and blurred vision.
  • 58% of practitioners said at least one patient experienced mild to moderate adverse effects like blurred vision, burning/stinging, and dysgeusia (taste disturbance).
  • Overall, the majority of practitioners (over 50%) were either moderately or very satisfied with lifitegrast for treating their dry eye patients.

The key takeaways highlighted were the high prevalence of dry eye disease, the importance of evaluating and addressing dry eye in all patients, and the practical benefits of having an effective and well-tolerated treatment option like lifitegrast available. The study demonstrates that lifitegrast can provide meaningful improvements in both signs and symptoms of dry eye in real-world clinical practice.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
© 2025 MJH Life Sciences

All rights reserved.